tirzepatide vs semaglutide weight loss trials I compare two medications with my patients every single week. Here's what the data actually shows. (Ozempic/Wegovy) delivered a 13.7% average weight loss in clinical trials. That's significant. But Semaglutide vs Tirzepatide: Which Helped

Heart Rate Acceleration With GLP-1 Receptor Agonists in Type 2 Diabetes Patients: An Acute and 12-Week Randomised, Double-Blind, Placebo-Controlled Trial

During weight loss, higher amounts (1.2-1.6 g/kg) may help preserve lean mass, though this should be individualized based on age, kidney function, and other health factors

Patients with a history of diabetic retinopathy should be monitored for progression of diabetic retinopathy Heart Rate Increase: Mean increases in resting heart rate of 1 to 4 beats per minute (bpm) were observed in Wegovy injection-treated adult patients compared to placebo in clinical trials

If youre looking to build on the initial progress and push towards your weight loss goals, Tier 2 provides the perfect stepping stone

Frequently Asked Questions 1Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial New England Journal of Medicine, 2023 2 3Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) New England Journal of Medicine, 2022 4Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) New England Journal of Medicine, 2021 5Glucagon receptor agonism enhances energy expenditure in obese subjects Cell Metabolism, 2023 Related Articles Comparison Tirzepatide vs Semaglutide: Which Weight Loss Medication Works Better

Since commercial patients tend to be younger and healthier than Medicare beneficiaries, early GLP-1 use is reinforcing its role as a reliable foundation for diabetes care and could be a contributing factor to rising rates of monotherapy